22nd Century Group (NASDAQ:XXII) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of 22nd Century Group (NASDAQ:XXII) to a sell rating in a research report report published on Thursday morning.

22nd Century Group Stock Performance

22nd Century Group stock opened at $1.24 on Thursday. The business has a 50 day moving average of $8.52 and a 200-day moving average of $35.55. The company has a market capitalization of $10.28 million, a P/E ratio of -0.01 and a beta of 1.50. 22nd Century Group has a 1 year low of $1.23 and a 1 year high of $164.40. The company has a debt-to-equity ratio of 0.01, a current ratio of 0.54 and a quick ratio of 0.43.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in 22nd Century Group stock. Anson Funds Management LP increased its stake in 22nd Century Group, Inc. (NASDAQ:XXII) by 106.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,577,814 shares of the biotechnology company’s stock after acquiring an additional 3,399,323 shares during the quarter. Anson Funds Management LP owned about 83.28% of 22nd Century Group worth $789,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 18.06% of the company’s stock.

About 22nd Century Group

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.